The risk of myocardial infarction and sudden cardiac death amongst snuff users with or without a previous history of smoking

Journal of Internal Medicine

Volumn 262, Issue 3, 2007, Pages 360-367

  Wennberg, P ^a,b,d   Eliasson, M ^b,c   Hallmans, G ^b   Johansson, L ^a,b   Boman, K ^a,b   Jansson, J H ^a,b  

^a Skelleftea Hospital   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

^c SUNDERBY HOSPITAL   (Sweden)

^d Forskningsenheten   (Sweden)

Author keywords

Myocardial infarction; Smokeless tobacco; Snuff; Sudden cardiac death

Indexed keywords

ADULT; ARTICLE; BODY MASS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY RISK; EDUCATIONAL STATUS; HEART INFARCTION; HUMAN; LEISURE; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; PHYSICAL ACTIVITY; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKELESS TOBACCO; SMOKING HABIT; SUDDEN DEATH; SURVIVAL TIME; SWEDEN;

DEATH, SUDDEN, CARDIAC; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; RISK FACTORS; SMOKING; SWEDEN; TOBACCO, SMOKELESS;

EID: 34547851177     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2007.01813.x     Document Type: Article

References (26)

1. Stegmayr B, Eliasson M, Rodu B. The decline of smoking in northern Sweden. Scand J Public Health 2005 33: 321 4 discussion 243.
2. Teo KK, Ounpuu S, Hawken S et al. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet 2006 368: 647 58.
3. Huhtasaari F, Asplund K, Lundberg V, Stegmayr B, Wester PO. Tobacco and myocardial infarction: is snuff less dangerous than cigarettes? BMJ 1992 305: 1252 6.
4. Bolinder G, Alfredsson L, Englund A, de Faire U. Smokeless tobacco use and increased cardiovascular mortality among Swedish construction workers. Am J Public Health 1994 84: 399 404.
5. Huhtasaari F, Lundberg V, Eliasson M, Janlert U, Asplund K. Smokeless tobacco as a possible risk factor for myocardial infarction: a population-based study in middle-aged men. J Am Coll Cardiol 1999 34: 1784 90.
6. Hergens MP, Ahlbom A, Andersson T, Pershagen G. Swedish moist snuff and myocardial infarction among men. Epidemiology 2005 16: 12 6.
7. Johansson SE, Sundquist K, Qvist J, Sundquist J. Smokeless tobacco and coronary heart disease: a 12-year follow-up study. Eur J Cardiovasc Prev Rehabil 2005 12: 387 92.
8. Benowitz NL, Gourlay SG. Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy. J Am Coll Cardiol 1997 29: 1422 31.
9. Stegmayr B, Lundberg V, Asplund K. The events registration and survey procedures in the Northern Sweden MONICA Project. Scand J Public Health Suppl 2003 61: 9 17.
10. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 1994 90: 583 612.
11. Messner T, Lundberg V, Bostrom S, Huhtasaari F, Wikstrom B. Trends in event rates of first and recurrent, fatal and non-fatal acute myocardial infarction, and 28-day case fatality in the Northern Sweden MONICA area 1985-98. Scand J Public Health Suppl 2003 61: 51 9.
12. Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Public Health 1989 79: 340 9.
13. Lightwood JM, Glantz SA. Short-term economic and health benefits of smoking cessation: myocardial infarction and stroke. Circulation 1997 96: 1089 96.
14. Bolinder G, Noren A, de Faire U, Wahren J. Smokeless tobacco use and atherosclerosis: an ultrasonographic investigation of carotid intima media thickness in healthy middle-aged men. Atherosclerosis 1997 132: 95 103.
15. Asplund K. Smokeless tobacco and cardiovascular disease. Prog Cardiovasc Dis 2003 45: 383 94.
16. Rohani M, Agewall S. Oral snuff impairs endothelial function in healthy snuff users. J Intern Med 2004 255: 379 83.
17. Eliasson M, Asplund K, Evrin PE, Lundblad D. Relationship of cigarette smoking and snuff dipping to plasma fibrinogen, fibrinolytic variables and serum insulin. The Northern Sweden MONICA Study. Atherosclerosis 1995 113: 41 53.
18. Wallenfeldt K, Hulthe J, Bokemark L, Wikstrand J, Fagerberg B. Carotid and femoral atherosclerosis, cardiovascular risk factors and C-reactive protein in relation to smokeless tobacco use or smoking in 58-year-old men. J Intern Med 2001 250: 492 501.
19. Kilaru S, Frangos SG, Chen AH et al. Nicotine: a review of its role in atherosclerosis. J Am Coll Surg 2001 193: 538 46.
20. Bolinder G, Noren A, Wahren J, De Faire U. Long-term use of smokeless tobacco and physical performance in middle-aged men. Eur J Clin Invest 1997 27: 427 33.
21. Wennmalm A, Benthin G, Granstrom EF, Persson L, Petersson AS, Winell S. Relation between tobacco consumption and urinary excretion of thromboxane A2 and prostacyclin metabolites in 756 randomly sampled young men. Adv Prostaglandin Thromboxane Leukot Res 1991 21B: 615 8.
22. Hirsch JM, Hedner J, Wernstedt L, Lundberg J, Hedner T. Hemodynamic effects of the use of oral snuff. Clin Pharmacol Ther 1992 52: 394 401.
23. Bolinder G, de Faire U. Ambulatory 24-h blood pressure monitoring in healthy, middle-aged smokeless tobacco users, smokers, and nontobacco users. Am J Hypertens 1998 11: 1153 63.
24. Eliasson M, Asplund K, Nasic S, Rodu B. Influence of smoking and snus on the prevalence and incidence of type 2 diabetes amongst men: the northern Sweden MONICA study. J Intern Med 2004 256: 101 10.
25. Persson PG, Carlsson S, Svanstrom L, Ostenson CG, Efendic S, Grill V. Cigarette smoking, oral moist snuff use and glucose intolerance. J Intern Med 2000 248: 103 10.
26. Norberg M, Stenlund H, Lindahl B, Boman K, Weinehall L. Contribution of Swedish moist snuff to the metabolic syndrome: a wolf in sheep's clothing Scand J Public Health 2006 34: 576 83.